Literature DB >> 26460906

Prolonged norovirus infection after pancreas transplantation: a case report and review of chronic norovirus.

I A Echenique1, V Stosor2,3, L Gallon3,4, D Kaufman5, C Qi6,7, T R Zembower2.   

Abstract

Norovirus is a major cause of self-limited gastroenteritis worldwide. Prevention and treatment are thwarted by rapid viral evolution, and thus supportive care remains the mainstay of therapy. Chronic infection in immunocompromised hosts is increasingly described. We report a case of norovirus infection lasting 2543 days in a pancreas transplant recipient. Serial fecal specimens were obtained, from which a map of genetic relatedness was derived. The clinical course was complicated by renal failure that progressed to end-stage renal disease. Minimization of immunosuppression was associated with resolution of the infection. Subsequently, the patient experienced a suspected allograft rejection that did not compromise pancreas function. The patient later underwent living-related renal transplantation without recurrence of enteritis.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic diarrhea; colitis; diarrhea; end-stage renal disease; gastroenteritis; norovirus; organ rejection; pancreas transplant; solid organ transplantation

Mesh:

Year:  2015        PMID: 26460906     DOI: 10.1111/tid.12472

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  9 in total

1.  Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.

Authors:  Wen Dang; Yuebang Yin; Yijin Wang; Wenshi Wang; Junhong Su; Dave Sprengers; Luc J W van der Laan; Krzysztof Felczak; Krzysztof W Pankiewicz; Kyeong-Ok Chang; Marion P G Koopmans; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 2.  Norovirus Regulation by Host and Microbe.

Authors:  Megan T Baldridge; Holly Turula; Christiane E Wobus
Journal:  Trends Mol Med       Date:  2016-11-22       Impact factor: 11.951

Review 3.  Chronic norovirus infection and common variable immunodeficiency.

Authors:  J Woodward; E Gkrania-Klotsas; D Kumararatne
Journal:  Clin Exp Immunol       Date:  2016-11-16       Impact factor: 4.330

4.  Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection.

Authors:  Inga Rimkute; Konrad Thorsteinsson; Marcus Henricsson; Victoria R Tenge; Xiaoming Yu; Shih-Ching Lin; Kei Haga; Robert L Atmar; Nils Lycke; Jonas Nilsson; Mary K Estes; Marta Bally; Göran Larson
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

Review 5.  Genetic Susceptibility to Human Norovirus Infection: An Update.

Authors:  Johan Nordgren; Lennart Svensson
Journal:  Viruses       Date:  2019-03-06       Impact factor: 5.048

Review 6.  Norovirus antivirals: Where are we now?

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Peter A White
Journal:  Med Res Rev       Date:  2018-12-25       Impact factor: 12.944

7.  Persistent elevation of aminotransferases in liver transplant in association with chronic norovirus infection.

Authors:  Ammar Abdulaziz Khayat; Grzegorz W Telega
Journal:  Clin Mol Hepatol       Date:  2019-05-07

8.  Long Term Norovirus Infection in a Patient with Severe Common Variable Immunodeficiency.

Authors:  Loa Ottosson; Marie Hagbom; Rikard Svernlöv; Sofia Nyström; Beatrice Carlsson; Mattias Öman; Magnus Ström; Lennart Svensson; Åsa Nilsdotter-Augustinsson; Johan Nordgren
Journal:  Viruses       Date:  2022-08-02       Impact factor: 5.818

9.  Intrahost Norovirus Evolution in Chronic Infection Over 5 Years of Shedding in a Kidney Transplant Recipient.

Authors:  Andrej Steyer; Tilen Konte; Martin Sagadin; Marko Kolenc; Andrej Škoberne; Julija Germ; Tadeja Dovč-Drnovšek; Miha Arnol; Mateja Poljšak-Prijatelj
Journal:  Front Microbiol       Date:  2018-03-02       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.